Degirmenci, M. Et Al. 2010. Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. MEDICAL ONCOLOGY , vol.27, no.3 , 585-591.

Degirmenci, M., KARACA, B., Gorumlu, G., DURUSOY ONMUŞ, İ. R., PISKIN, G. D., BOZKURT, M. T., ... Cirak, Y.(2010). Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. MEDICAL ONCOLOGY , vol.27, no.3, 585-591.

Degirmenci, M. Et Al. "Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer," MEDICAL ONCOLOGY , vol.27, no.3, 585-591, 2010

Degirmenci, M. Et Al. "Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer." MEDICAL ONCOLOGY , vol.27, no.3, pp.585-591, 2010

Degirmenci, M. Et Al. (2010) . "Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer." MEDICAL ONCOLOGY , vol.27, no.3, pp.585-591.

@article{article, author={M. Degirmenci Et Al. }, title={Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer}, journal={MEDICAL ONCOLOGY}, year=2010, pages={585-591} }